The Journal of Immunology · 2014 · 14 citations · 17 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationImmunotherapyB Cell BiologyB-cell ResponsesCell-mediated ImmunityInflammatory Response RegulationRegulatory T CellsT Cell BiologyAntigen-specific Immune ResponseB-1 CellsB-cell Mediated ImmunityCd4 Positive T CellsPeripheral Regulatory T CellsRegulatory B Cell FunctionRegulatory B Cell ResponsesTargeted Immunization
The immunosuppressant dexamethasone was shown to preferentially deplete CD4+ effector T cells while sparing regulatory T cells (Tregs) in vivo. In the current study, we show that it also preferentially depletes B-2 cells while sparing B-1 cells. In the ApoE(-/-) mouse model of atherosclerosis, in which both Tregs and B-1 cells are thought to play an atheroprotective role, we show that HSP60-targeted immunization in the presence of dexamethasone raises Ag-reactive Tregs and B-1 cells concomitantly and reduces the severity of atherosclerosis. These results indicate that dexamethasone is an adjuvant that potentiates both the Treg and B-1 responses to immunogens. This study shows that B-1 cells with a specificity for a disease-relevant Ag can be raised in vivo by immunization.
17
Xin Chen, Takaya Murakami, Joost J. Oppenheim et al. · European Journal of Immunology · 2004 · 197 citations · Full text